Coping with bioterrorism

Publisher Website
Google Scholar
Abstract
References 1.↵ Institute of Medicine and National Research Council. Chemical and biological terrorism: research and development to improve civilian medical response. Washington, DC: National Academy Press, 1999. 2.↵ Roberts B Fainberg A . Debating policy priorities and implications. In: Roberts B ed. Terrorism with chemical and biological weapons. Alexandria, VA: Chemical and Biological Arms Control Institute, 1997: 75–93. 3.↵ Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Byrne WR, et al . Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278: 399–411. 4.↵ Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al . The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266: 1202–1208. 5.↵ Morita H, Yanigasawa T, Shimizu M, Hirabayashi H, Okudera H, Nohara M, et al . Sarin poisioning in Matsumoto, Japan. Lancet 1995; 346: 290–293. 6. Okumura T, Suzuki K, Kukuda A, Kohama A, Takasu N, Ishimatsu S, et al . The Tokyo subway sarin attack: disaster management, part 1: community emergency response. Acad Emerg Med 1998; 5: 613–617. 7. Okumura T, Suzuki K, Kukuda A, Kohama A, Takasu N, Ishimatsu S, et al . The Tokyo subway sarin attack: disaster management, part 2: hospital response. Acad Emerg Med 1998; 5: 618–624. 8.↵ Okumura T, Suzuki K, Kukuda A, Kohama A, Takasu N, Ishimatsu S, et al . The Tokyo subway sarin attack: disaster management, part 3. Acad Emerg Med 1998; 5: 628–652. 9.↵ Belmonte RB . Tests of level A suits: protection against chemical and biological warfare agents and simulants: executive summary. Aberdeen Proving Ground, MD: Edgewood Research, Development, and Engineering Center, 1997. 10.↵ Bowler RM, Huel D, Mergler G, Cone J . Psychological, psychosocial, and psycho-physiological sequelae in a community affected by a railroad chemical disaster. J Traumatic Stress 1994; 7: 601–624.